SEC Form 4 · accession 0001209191-16-145484
HERON THERAPEUTICS, INC. /DE/ · HRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Craig A Johnson
Director
Period of report
Oct 7, 2016
Accepted (ET)
Oct 7, 2016 · 9:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000818033
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $16.83 | Oct 7, 2016 | A | 50,000 | A | Oct 7, 2017 | Oct 7, 2026 | Common Stock | 50,000 | 50,000 | D |